Benitec Biopharma, Inc. (BNTC)
8.98
-0.60
(-6.26%)
USD |
NASDAQ |
Oct 02, 16:00
8.95
-0.03
(-0.33%)
After-Hours: 20:00
Benitec Biopharma Price to Book Value : 1.746 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.746 |
| October 01, 2026 | 1.863 |
| September 30, 2026 | 1.944 |
| September 29, 2026 | 1.896 |
| September 28, 2026 | 1.948 |
| September 25, 2026 | 1.865 |
| September 24, 2026 | 1.874 |
| September 23, 2026 | 1.911 |
| September 22, 2026 | 2.129 |
| September 21, 2026 | 2.115 |
| September 18, 2026 | 2.143 |
| September 17, 2026 | 2.209 |
| September 16, 2026 | 2.146 |
| September 15, 2026 | 2.148 |
| September 14, 2026 | 2.349 |
| September 11, 2026 | 2.370 |
| September 10, 2026 | 2.376 |
| September 09, 2026 | 2.421 |
| September 08, 2026 | 2.474 |
| September 04, 2026 | 2.465 |
| September 03, 2026 | 2.419 |
| September 02, 2026 | 2.504 |
| September 01, 2026 | 2.393 |
| August 31, 2026 | 2.366 |
| August 28, 2026 | 2.425 |
| Date | Value |
|---|---|
| August 27, 2026 | 2.463 |
| August 26, 2026 | 2.504 |
| August 25, 2026 | 2.532 |
| August 24, 2026 | 2.471 |
| August 21, 2026 | 2.621 |
| August 20, 2026 | 2.530 |
| August 19, 2026 | 2.602 |
| August 18, 2026 | 2.504 |
| August 17, 2026 | 2.541 |
| August 14, 2026 | 2.442 |
| August 13, 2026 | 2.442 |
| August 12, 2026 | 2.399 |
| August 11, 2026 | 2.621 |
| August 10, 2026 | 2.679 |
| August 07, 2026 | 2.650 |
| August 06, 2026 | 2.553 |
| August 05, 2026 | 2.467 |
| August 04, 2026 | 2.434 |
| August 03, 2026 | 2.362 |
| July 31, 2026 | 2.277 |
| July 30, 2026 | 2.306 |
| July 29, 2026 | 2.343 |
| July 28, 2026 | 2.312 |
| July 27, 2026 | 2.252 |
| July 24, 2026 | 2.230 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.628 |
| Alnylam Pharmaceuticals, Inc. | 21.70 |
| Savara, Inc. | 6.877 |
| Vericel Corp. | 5.552 |
| Biogen, Inc. | 1.723 |
Price to Book Value Related Metrics
| Price | 8.98 |
| Earnings Yield | -12.11% |
| Market Cap | 309.06M |